Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation

Anal cancer is a rare disease with increasing incidence. In patients with locally recurrent or metastatic disease which cannot be treated with chemoradiotherapy or salvage surgery systemic first-line chemotherapy with carboplatin and paclitaxel is standard of care. For patients who progress after fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Demes, Melanie, Pession, Ursula, Jeroch, Jan, Schulze, Falko, Eichler, Katrin, Martin, Daniel, Wild, Peter, Waidmann, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477220/
https://www.ncbi.nlm.nih.gov/pubmed/36128324
http://dx.doi.org/10.18632/oncotarget.28274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477220/
https://www.ncbi.nlm.nih.gov/pubmed/36128324
http://dx.doi.org/10.18632/oncotarget.28274

Ejemplares similares